Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A novel Bacillus subtilis expression vector based on bacteriophage phi 105.

R M Gibson1, J Errington

  • 1Sir William Dunn School of Pathology, University of Oxford, UK.

Gene
|November 2, 1992
PubMed
Summary

Researchers created a new bacteriophage phi 105 vector for producing mutant beta-lactamases in Bacillus subtilis. This engineered phage allows for controlled protein production without cell lysis, simplifying purification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and advanced neurophysiology in the prognostic and diagnostic evaluation of disorders of consciousness: review of an IFCN-endorsed expert group.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2020
Same author

Population pharmacokinetics of carboplatin, etoposide and melphalan in children: a re-evaluation of paediatric dosing formulas for carboplatin in patients with normal or mild impairment of renal function.

British journal of clinical pharmacology·2018
Same author

Pooling of genital swabs for detection by PCR of Taylorella equigenitalis, the cause of contagious equine metritis.

Equine veterinary journal·2018
Same author

Brain-computer interfaces for patients with disorders of consciousness.

Progress in brain research·2016
Same author

Increased phylogenetic diversity of bovine viral diarrhoea virus type 1 isolates in England and Wales since 2001.

Veterinary microbiology·2012
Same author

Prevalence of Coxiella burnetii in livestock abortion material using PCR.

The Veterinary record·2011

Area of Science:

  • Molecular Biology
  • Microbial Genetics
  • Biotechnology

Background:

  • Bacteriophage phi 105 is a potential tool for genetic manipulation in Bacillus subtilis.
  • Efficient expression of heterologous genes in B. subtilis requires optimized vector systems.
  • Beta-lactamases are important enzymes with applications in various biological and medical fields.

Purpose of the Study:

  • To develop a novel bacteriophage phi 105-based expression vector for producing mutant beta-lactamases in Bacillus subtilis.
  • To enhance the expression levels of beta-lactamase genes within the B. subtilis host.
  • To engineer a system for inducible and lysis-free protein production.

Main Methods:

  • Construction of a modified bacteriophage phi 105 vector with specific deletions and temperature-sensitive mutations.

Related Experiment Videos

  • Cloning of beta-lactamase-encoding genes into the phage genome under different promoter controls.
  • Optimization of gene insertion orientation relative to phage transcription.
  • Induction of protein production via temperature shifts and assessment of cell lysis.

    • Main Results:

    • Low expression of beta-lactamase when cloned under its native promoter within the prophage.
    • Significantly elevated expression when the gene was inserted in the same orientation as phage transcription.
    • Successful construction of a defective phi 105 vector enabling temperature-inducible expression.
    • Facilitated purification of beta-lactamase from the culture supernatant due to the absence of cell lysis.

    Conclusions:

    • The engineered bacteriophage phi 105 vector provides a controllable system for heterologous protein production in Bacillus subtilis.
    • Optimizing gene insertion orientation and utilizing a temperature-sensitive lysis-defective vector are key for efficient, lysis-free protein expression.
    • This novel phage vector holds significant potential for the biotechnological production of valuable proteins in B. subtilis.